JP5016669B2 - 神経刺激を使用する、atp治療を改善するためのシステム - Google Patents
神経刺激を使用する、atp治療を改善するためのシステム Download PDFInfo
- Publication number
- JP5016669B2 JP5016669B2 JP2009509919A JP2009509919A JP5016669B2 JP 5016669 B2 JP5016669 B2 JP 5016669B2 JP 2009509919 A JP2009509919 A JP 2009509919A JP 2009509919 A JP2009509919 A JP 2009509919A JP 5016669 B2 JP5016669 B2 JP 5016669B2
- Authority
- JP
- Japan
- Prior art keywords
- therapy
- feature set
- heart rate
- atp
- tachyarrhythmia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002560 therapeutic procedure Methods 0.000 title claims description 117
- 230000000638 stimulation Effects 0.000 title claims description 81
- 230000001537 neural effect Effects 0.000 title claims description 74
- 208000001871 Tachycardia Diseases 0.000 claims description 109
- 210000002216 heart Anatomy 0.000 claims description 91
- 206010047302 ventricular tachycardia Diseases 0.000 claims description 76
- 206010049447 Tachyarrhythmia Diseases 0.000 claims description 64
- 238000002633 shock therapy Methods 0.000 claims description 29
- 230000033764 rhythmic process Effects 0.000 claims description 18
- 230000000004 hemodynamic effect Effects 0.000 claims description 14
- 210000001186 vagus nerve Anatomy 0.000 claims description 14
- 210000005036 nerve Anatomy 0.000 claims description 11
- 238000013507 mapping Methods 0.000 claims description 7
- 230000008722 morphological abnormality Effects 0.000 claims description 7
- 230000004936 stimulating effect Effects 0.000 claims description 5
- 230000006866 deterioration Effects 0.000 claims description 4
- 210000004731 jugular vein Anatomy 0.000 claims description 3
- 238000011282 treatment Methods 0.000 description 58
- 238000000034 method Methods 0.000 description 38
- 230000035939 shock Effects 0.000 description 21
- 230000006794 tachycardia Effects 0.000 description 18
- 239000002131 composite material Substances 0.000 description 15
- 230000000747 cardiac effect Effects 0.000 description 14
- 238000004891 communication Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 230000001734 parasympathetic effect Effects 0.000 description 10
- 230000002889 sympathetic effect Effects 0.000 description 10
- 238000007726 management method Methods 0.000 description 9
- 230000002107 myocardial effect Effects 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 8
- 206010003119 arrhythmia Diseases 0.000 description 7
- 230000006793 arrhythmia Effects 0.000 description 6
- 238000013194 cardioversion Methods 0.000 description 6
- 238000002635 electroconvulsive therapy Methods 0.000 description 6
- 230000002861 ventricular Effects 0.000 description 6
- 230000001746 atrial effect Effects 0.000 description 5
- 230000007383 nerve stimulation Effects 0.000 description 5
- 238000000718 qrs complex Methods 0.000 description 5
- 208000003663 ventricular fibrillation Diseases 0.000 description 5
- 108091008698 baroreceptors Proteins 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000001774 pressoreceptor Anatomy 0.000 description 4
- 206010003658 Atrial Fibrillation Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000036471 bradycardia Effects 0.000 description 3
- 208000006218 bradycardia Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002837 heart atrium Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000028161 membrane depolarization Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000008701 parasympathetic activation Effects 0.000 description 3
- 230000008700 sympathetic activation Effects 0.000 description 3
- 206010001497 Agitation Diseases 0.000 description 2
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 2
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 2
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 206010003668 atrial tachycardia Diseases 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 206010061592 cardiac fibrillation Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 230000002600 fibrillogenic effect Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000001013 sinoatrial node Anatomy 0.000 description 2
- 210000002820 sympathetic nervous system Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 1
- 241001632160 Dismorphiinae Species 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000007888 Sinus Tachycardia Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 206010065341 Ventricular tachyarrhythmia Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000035581 baroreflex Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 210000001326 carotid sinus Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 208000037909 invasive meningococcal disease Diseases 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000009158 reflex pathway Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3621—Heart stimulators for treating or preventing abnormally high heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36564—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
- A61N1/3962—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
- A61N1/39622—Pacing therapy
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/382,120 US8255049B2 (en) | 2006-05-08 | 2006-05-08 | Method and device for providing anti-tachyarrhythmia therapy |
| US11/382,120 | 2006-05-08 | ||
| PCT/US2007/066741 WO2007133877A2 (en) | 2006-05-08 | 2007-04-17 | System to improve atp therapy using neurostimulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009536558A JP2009536558A (ja) | 2009-10-15 |
| JP2009536558A5 JP2009536558A5 (enExample) | 2010-04-02 |
| JP5016669B2 true JP5016669B2 (ja) | 2012-09-05 |
Family
ID=38662109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009509919A Expired - Fee Related JP5016669B2 (ja) | 2006-05-08 | 2007-04-17 | 神経刺激を使用する、atp治療を改善するためのシステム |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8255049B2 (enExample) |
| EP (1) | EP2021075B1 (enExample) |
| JP (1) | JP5016669B2 (enExample) |
| WO (1) | WO2007133877A2 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1712542A4 (en) * | 2004-02-05 | 2008-01-16 | Idemitsu Kosan Co | ADAMANTANE DERIVATIVES AND METHOD OF PRODUCTION |
| US8055340B2 (en) * | 2005-05-05 | 2011-11-08 | Cardiac Pacemakers, Inc. | Method and device for comprehensive anti-tachyarrhythmia therapy |
| US8255049B2 (en) | 2006-05-08 | 2012-08-28 | Cardiac Pacemakers, Inc. | Method and device for providing anti-tachyarrhythmia therapy |
| US8983598B2 (en) * | 2006-10-04 | 2015-03-17 | Cardiac Pacemakers, Inc. | System for neurally-mediated anti-arrhythmic therapy |
| US8706212B2 (en) | 2006-12-13 | 2014-04-22 | Cardiac Pacemakers, Inc. | Neural stimulation systems, devices and methods |
| US8437849B2 (en) * | 2007-01-30 | 2013-05-07 | Cardiac Pacemakers, Inc. | Method and apparatus for atrial pacing during tachyarrhythmia |
| US8233982B2 (en) * | 2007-02-21 | 2012-07-31 | Cardiac Pacemakers, Inc. | Systems and methods for treating supraventricular arrhythmias |
| US20080281372A1 (en) * | 2007-05-09 | 2008-11-13 | Cardiac Pacemakers, Inc. | Neural stimulation system analyzer |
| US8170669B2 (en) * | 2007-10-10 | 2012-05-01 | Cardiac Pacemakers, Inc. | Method and apparatus for concurrent atrio-ventricular anti-tachycardia pacing |
| EP2268355B1 (en) | 2008-03-13 | 2015-09-30 | Cardiac Pacemakers, Inc. | Systems and devices for modulating autonomic tone |
| US8812108B2 (en) * | 2008-03-13 | 2014-08-19 | Cardiac Pacemakers, Inc. | Autonomic balance monitoring to control intermittent therapy |
| US8706220B2 (en) * | 2008-04-09 | 2014-04-22 | Medtronic, Inc. | Method and apparatus for detecting and treating tachyarrhythmias incorporating diagnostic/therapeutic pacing techniques |
| US8244350B2 (en) * | 2008-08-05 | 2012-08-14 | Cardiac Pacemakers, Inc. | Neural stimulation for arrhythmia recognition and therapy |
| US9289613B2 (en) | 2008-10-31 | 2016-03-22 | Medtronic, Inc. | Interdevice impedance |
| EP2370173A2 (en) * | 2008-10-31 | 2011-10-05 | Medtronic, Inc. | Interference mitigation for implantable device recharging |
| US8265771B2 (en) * | 2008-10-31 | 2012-09-11 | Medtronic, Inc. | Interference mitigation for implantable device recharging |
| US8452394B2 (en) * | 2008-10-31 | 2013-05-28 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8260412B2 (en) * | 2008-10-31 | 2012-09-04 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8612020B2 (en) * | 2008-10-31 | 2013-12-17 | Medtronic, Inc. | Implantable therapeutic nerve stimulator |
| US20100114209A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Communication between implantable medical devices |
| US8688210B2 (en) | 2008-10-31 | 2014-04-01 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8301263B2 (en) * | 2008-10-31 | 2012-10-30 | Medtronic, Inc. | Therapy module crosstalk mitigation |
| US8774918B2 (en) | 2008-10-31 | 2014-07-08 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US9775987B2 (en) * | 2008-10-31 | 2017-10-03 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| WO2010051499A1 (en) | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Therapy system including cardiac rhythm therapy and neurostimulation capabilities |
| US8005539B2 (en) * | 2008-10-31 | 2011-08-23 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8611996B2 (en) * | 2008-10-31 | 2013-12-17 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8532779B2 (en) * | 2008-10-31 | 2013-09-10 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8249708B2 (en) * | 2008-10-31 | 2012-08-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US9597505B2 (en) | 2008-10-31 | 2017-03-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| EP2401030A1 (en) | 2009-01-30 | 2012-01-04 | Medtronic, Inc. | Detecting and treating electromechanical dissociation of the heart |
| WO2010123679A1 (en) * | 2009-04-22 | 2010-10-28 | Cardiac Pacemakers, Inc. | Dynamic selection of algorithms for arrhythmia detection |
| US20110201945A1 (en) * | 2010-02-17 | 2011-08-18 | Dan Li | Hemodynamic stability detection during arrhythmia using respiration sensor |
| US8903490B2 (en) * | 2010-03-03 | 2014-12-02 | Cardiac Pacemakers, Inc. | Methods and systems for recognizing arrhythmias using neural stimulation |
| US8639327B2 (en) | 2010-04-29 | 2014-01-28 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
| US8423134B2 (en) | 2010-04-29 | 2013-04-16 | Medtronic, Inc. | Therapy using perturbation and effect of physiological systems |
| JP5608812B2 (ja) | 2010-05-07 | 2014-10-15 | カーディアック ペースメイカーズ, インコーポレイテッド | 電気刺激と神経調節の両方のための出力回路 |
| US8781582B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
| US8718763B2 (en) | 2011-01-19 | 2014-05-06 | Medtronic, Inc. | Vagal stimulation |
| US8706223B2 (en) | 2011-01-19 | 2014-04-22 | Medtronic, Inc. | Preventative vagal stimulation |
| US8725259B2 (en) | 2011-01-19 | 2014-05-13 | Medtronic, Inc. | Vagal stimulation |
| EP2785412B1 (en) | 2011-11-29 | 2017-07-12 | Cardiac Pacemakers, Inc. | Autonomic modulation using peripheral nerve field stimulation |
| US8600500B1 (en) | 2012-12-11 | 2013-12-03 | Pacesetter, Inc. | Method and system to provide neural stimulation therapy to assist anti-tachycardia pacing therapy |
| WO2016057544A1 (en) | 2014-10-07 | 2016-04-14 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
| US10765875B2 (en) | 2017-05-04 | 2020-09-08 | University Of Utah Research Foundation | Implantable cardiac devices and methods for delivering low energy, pain-free defibrillation signals for ventricular arrhythmias |
| EP4291294A1 (en) | 2021-04-27 | 2023-12-20 | Boston Scientific Neuromodulation Corporation | Systems and methods for automated programming of electrical stimulation |
| EP4313278A1 (en) * | 2021-06-07 | 2024-02-07 | Boston Scientific Neuromodulation Corporation | Stimulation systems with user-specified routines and methods of making and using |
| EP4313269A1 (en) | 2021-06-15 | 2024-02-07 | Boston Scientific Neuromodulation Corporation | Methods and systems for estimating neural activation by stimulation using a stimulation system |
| EP4415809A2 (en) | 2021-12-10 | 2024-08-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using response maps for electrical stimulation |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5405363A (en) | 1991-03-15 | 1995-04-11 | Angelon Corporation | Implantable cardioverter defibrillator having a smaller displacement volume |
| US5203326A (en) | 1991-12-18 | 1993-04-20 | Telectronics Pacing Systems, Inc. | Antiarrhythmia pacer using antiarrhythmia pacing and autonomic nerve stimulation therapy |
| US5697953A (en) | 1993-03-13 | 1997-12-16 | Angeion Corporation | Implantable cardioverter defibrillator having a smaller displacement volume |
| US5957956A (en) | 1994-06-21 | 1999-09-28 | Angeion Corp | Implantable cardioverter defibrillator having a smaller mass |
| EP0688579B1 (en) | 1994-06-24 | 2001-08-22 | St. Jude Medical AB | Device for heart therapy |
| EP0688578B1 (en) | 1994-06-24 | 1999-11-10 | Pacesetter AB | Arrhythmia detector |
| EP0688577A1 (en) | 1994-06-24 | 1995-12-27 | Pacesetter AB | Device for treating atrial tachyarrhythmia |
| US5662689A (en) | 1995-09-08 | 1997-09-02 | Medtronic, Inc. | Method and apparatus for alleviating cardioversion shock pain |
| US5954752A (en) | 1997-04-30 | 1999-09-21 | Medtronic, Inc. | Cardioversion energy reduction system |
| US5836976A (en) | 1997-04-30 | 1998-11-17 | Medtronic, Inc. | Cardioversion energy reduction system |
| WO1999065561A1 (en) | 1998-06-19 | 1999-12-23 | Cordis Webster, Inc. | Method and apparatus for transvascular treatment of tachycardia and fibrillation |
| US6668191B1 (en) | 1998-10-26 | 2003-12-23 | Birinder R. Boveja | Apparatus and method for electrical stimulation adjunct (add-on) therapy of atrial fibrillation, inappropriate sinus tachycardia, and refractory hypertension with an external stimulator |
| US6134470A (en) | 1998-11-09 | 2000-10-17 | Medtronic, Inc. | Method and apparatus for treating a tachyarrhythmic patient |
| US6611713B2 (en) | 1999-11-30 | 2003-08-26 | Patrick Schauerte | Implantable device for diagnosing and distinguishing supraventricular and ventricular tachycardias |
| US6567691B1 (en) | 2000-03-22 | 2003-05-20 | Medtronic, Inc. | Method and apparatus diagnosis and treatment of arrhythias |
| US6896159B2 (en) * | 2000-06-08 | 2005-05-24 | Beverage Works, Inc. | Beverage dispensing apparatus having fluid director |
| US6950705B2 (en) | 2000-09-18 | 2005-09-27 | Cameron Health, Inc. | Canister designs for implantable cardioverter-defibrillators |
| US7043299B2 (en) | 2000-09-18 | 2006-05-09 | Cameron Health, Inc. | Subcutaneous implantable cardioverter-defibrillator employing a telescoping lead |
| US7120495B2 (en) | 2000-09-18 | 2006-10-10 | Cameron Health, Inc. | Flexible subcutaneous implantable cardioverter-defibrillator |
| US6952610B2 (en) | 2000-09-18 | 2005-10-04 | Cameron Health, Inc. | Current waveforms for anti-tachycardia pacing for a subcutaneous implantable cardioverter- defibrillator |
| US6788974B2 (en) | 2000-09-18 | 2004-09-07 | Cameron Health, Inc. | Radian curve shaped implantable cardioverter-defibrillator canister |
| US6988003B2 (en) | 2000-09-18 | 2006-01-17 | Cameron Health, Inc. | Implantable cardioverter-defibrillator having two spaced apart shocking electrodes on housing |
| US7069080B2 (en) | 2000-09-18 | 2006-06-27 | Cameron Health, Inc. | Active housing and subcutaneous electrode cardioversion/defibrillating system |
| US6721597B1 (en) | 2000-09-18 | 2004-04-13 | Cameron Health, Inc. | Subcutaneous only implantable cardioverter defibrillator and optional pacer |
| US6647292B1 (en) | 2000-09-18 | 2003-11-11 | Cameron Health | Unitary subcutaneous only implantable cardioverter-defibrillator and optional pacer |
| JP2004513752A (ja) | 2000-11-22 | 2004-05-13 | メドトロニック,インコーポレイテッド | 心室性不整脈を検出しかつ治療するための装置 |
| US7519421B2 (en) | 2001-01-16 | 2009-04-14 | Kenergy, Inc. | Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation |
| US6571125B2 (en) | 2001-02-12 | 2003-05-27 | Medtronic, Inc. | Drug delivery device |
| US6658286B2 (en) * | 2001-04-06 | 2003-12-02 | Cardiac Pacemakers, Inc. | Atrial and ventricular tachyarrhythmia detection system and method |
| JP2004533297A (ja) | 2001-05-29 | 2004-11-04 | メドトロニック・インコーポレーテッド | 心臓病の予防及び処置のための閉ループ神経調節システム |
| US6718204B2 (en) * | 2001-07-30 | 2004-04-06 | Medtronic, Inc. | Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device |
| US7778711B2 (en) | 2001-08-31 | 2010-08-17 | Bio Control Medical (B.C.M.) Ltd. | Reduction of heart rate variability by parasympathetic stimulation |
| US6934583B2 (en) | 2001-10-22 | 2005-08-23 | Pacesetter, Inc. | Implantable lead and method for stimulating the vagus nerve |
| US7123959B2 (en) | 2002-03-25 | 2006-10-17 | Cardiac Pacemakers, Inc. | Method and apparatus for preventing cardiac arrhythmias with endovascular stimulation |
| US6922585B2 (en) | 2002-04-05 | 2005-07-26 | Medtronic, Inc. | Method and apparatus for predicting recurring ventricular arrhythmias |
| US8204591B2 (en) | 2002-05-23 | 2012-06-19 | Bio Control Medical (B.C.M.) Ltd. | Techniques for prevention of atrial fibrillation |
| US7321793B2 (en) | 2003-06-13 | 2008-01-22 | Biocontrol Medical Ltd. | Vagal stimulation for atrial fibrillation therapy |
| US7225017B1 (en) | 2002-06-12 | 2007-05-29 | Pacesetter, Inc. | Parasympathetic nerve stimulation for ICD and/or ATP patients |
| US7245967B1 (en) | 2002-06-12 | 2007-07-17 | Pacesetter, Inc. | Parasympathetic nerve stimulation for termination of supraventricular arrhythmias |
| US7292890B2 (en) * | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
| US6931278B1 (en) | 2002-12-06 | 2005-08-16 | Pacesetter, Inc. | Implantable cardioverter defibrillator having fast action operation |
| US7302294B2 (en) | 2003-04-11 | 2007-11-27 | Cardiac Pacemakers, Inc. | Subcutaneous cardiac sensing and stimulation system employing blood sensor |
| US7130681B2 (en) * | 2003-05-09 | 2006-10-31 | Medtronic, Inc. | Use of accelerometer signal to augment ventricular arrhythmia detection |
| US8060197B2 (en) | 2003-05-23 | 2011-11-15 | Bio Control Medical (B.C.M.) Ltd. | Parasympathetic stimulation for termination of non-sinus atrial tachycardia |
| US20080046016A1 (en) | 2003-05-23 | 2008-02-21 | Biocontrol Medical Ltd. | Intravascular parasympatheticstimulation for atrial cardioversion |
| JP4213522B2 (ja) | 2003-05-30 | 2009-01-21 | テルモ株式会社 | 心臓治療装置 |
| WO2004110549A2 (en) | 2003-06-13 | 2004-12-23 | Biocontrol Medical Ltd. | Applications of vagal stimulation |
| US20050131467A1 (en) | 2003-11-02 | 2005-06-16 | Boveja Birinder R. | Method and apparatus for electrical stimulation therapy for at least one of atrial fibrillation, congestive heart failure, inappropriate sinus tachycardia, and refractory hypertension |
| US7532929B2 (en) * | 2004-02-23 | 2009-05-12 | Biotronik Crm Patent Ag | Adaptive ventricular rate smoothing during atrial fibrillation |
| US20060004417A1 (en) | 2004-06-30 | 2006-01-05 | Cvrx, Inc. | Baroreflex activation for arrhythmia treatment |
| EP2380626B1 (en) | 2004-09-30 | 2015-03-04 | Cardiac Pacemakers, Inc. | Arrhythmia classification and therapy selection |
| AR047851A1 (es) | 2004-12-20 | 2006-03-01 | Giniger Alberto German | Un nuevo marcapasos que restablece o preserva la conduccion electrica fisiologica del corazon y un metodo de aplicacion |
| US7587238B2 (en) | 2005-03-11 | 2009-09-08 | Cardiac Pacemakers, Inc. | Combined neural stimulation and cardiac resynchronization therapy |
| WO2006098996A1 (en) | 2005-03-11 | 2006-09-21 | Cardiac Pacemakers, Inc. | Combined neural stimulation and cardiac resynchronization therapy |
| US8055340B2 (en) | 2005-05-05 | 2011-11-08 | Cardiac Pacemakers, Inc. | Method and device for comprehensive anti-tachyarrhythmia therapy |
| US8255049B2 (en) | 2006-05-08 | 2012-08-28 | Cardiac Pacemakers, Inc. | Method and device for providing anti-tachyarrhythmia therapy |
| US8983598B2 (en) | 2006-10-04 | 2015-03-17 | Cardiac Pacemakers, Inc. | System for neurally-mediated anti-arrhythmic therapy |
| US20080269819A1 (en) | 2007-04-26 | 2008-10-30 | Xiaohong Zhou | Discrimination of supraventricular tachycardia from ventricular tachycardia |
| US8244350B2 (en) | 2008-08-05 | 2012-08-14 | Cardiac Pacemakers, Inc. | Neural stimulation for arrhythmia recognition and therapy |
-
2006
- 2006-05-08 US US11/382,120 patent/US8255049B2/en not_active Expired - Fee Related
-
2007
- 2007-04-17 WO PCT/US2007/066741 patent/WO2007133877A2/en not_active Ceased
- 2007-04-17 EP EP07760739.8A patent/EP2021075B1/en not_active Not-in-force
- 2007-04-17 JP JP2009509919A patent/JP5016669B2/ja not_active Expired - Fee Related
-
2012
- 2012-08-08 US US13/569,208 patent/US9084898B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007133877A2 (en) | 2007-11-22 |
| US20120296383A1 (en) | 2012-11-22 |
| US8255049B2 (en) | 2012-08-28 |
| JP2009536558A (ja) | 2009-10-15 |
| EP2021075B1 (en) | 2014-10-15 |
| US9084898B2 (en) | 2015-07-21 |
| WO2007133877A3 (en) | 2008-03-20 |
| EP2021075A2 (en) | 2009-02-11 |
| US20070260283A1 (en) | 2007-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5016669B2 (ja) | 神経刺激を使用する、atp治療を改善するためのシステム | |
| US11890481B2 (en) | AV nodal stimulation during atrial tachyarrhythmia to prevent inappropriate therapy delivery | |
| US8965503B2 (en) | Systems and methods for treating supraventricular arrhythmias | |
| US8983598B2 (en) | System for neurally-mediated anti-arrhythmic therapy | |
| US9186522B2 (en) | Neural stimulation systems, devices and methods | |
| JP4395075B2 (ja) | 不整脈を防止するストレス低減ペーシング・モード | |
| JP2620819B2 (ja) | 心臓虚血制御装置 | |
| JP4343107B2 (ja) | 過駆動ペーシングを用いて連続的に発生する不整脈を予防する方法および装置 | |
| US20100121399A1 (en) | Closed loop neural stimulation synchronized to cardiac cycles | |
| JP2005529690A5 (enExample) | ||
| EP1888167A1 (en) | Device for comprehensive anti-tachyarrhythmia therapy | |
| US8903490B2 (en) | Methods and systems for recognizing arrhythmias using neural stimulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100118 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20100118 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100210 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100210 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100715 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100715 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120120 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120410 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120529 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120608 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150615 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D03 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |